{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T15:33:25Z","timestamp":1692804805818},"reference-count":20,"publisher":"Medwave Estudios Limitada","issue":"Suppl1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2015.6168","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T19:23:47Z","timestamp":1435346627000},"page":"e6168-e6168","source":"Crossref","is-referenced-by-count":3,"title":["Is carvedilol better than other beta-blockers for heart failure?"],"prefix":"10.5867","volume":"15","author":[{"given":"Carmen","family":"Rain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Rada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"issue":"8","key":"ref0","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.amjcard.2015.01.545","article-title":"Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure.","volume":"115","author":"Briasoulis","year":"2015","unstructured":"Briasoulis A, Palla M, Afonso L. Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure. Am J Cardiol. 2015 Apr 15;115(8):1111-5. | CrossRef | PubMed |","journal-title":"Am J Cardiol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.","volume":"346","author":"Chatterjee","year":"2013","unstructured":"Chatterjee S, Biondi-Zoccai G, Abbate A, D'Ascenzo F, Castagno D, Van Tassell B, et al. Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ. 2013 Jan 16;346:f55. | CrossRef | PubMed |","journal-title":"BMJ","ISSN":"http:\/\/id.crossref.org\/issn\/0959-8138","issn-type":"print"},{"issue":"9","key":"ref2","first-page":"284","article-title":"A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.","volume":"67","author":"de Peuter","year":"2009","unstructured":"de Peuter OR, Lussana F, Peters RJ, B\u00fcller HR, Kamphuisen PW. A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. Neth J Med. 2009 Oct;67(9):284-94. | PubMed |","journal-title":"Neth J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0300-2977","issn-type":"print"},{"issue":"3","key":"ref3","first-page":"168","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013 Mar 1;111(5):765-9. | CrossRef | PubMed | Aygul N, Ozdemir K, Duzenli MA, Aygul MU. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.","volume":"112","author":"DiNicolantonio","year":"2009","unstructured":"DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013 Mar 1;111(5):765-9. | CrossRef | PubMed | Aygul N, Ozdemir K, Duzenli MA, Aygul MU. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure. Cardiology. 2009;112(3):168-73. | CrossRef | PubMed |","journal-title":"Cardiology","ISSN":"http:\/\/id.crossref.org\/issn\/0008-6312","issn-type":"print"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijcard.2004.05.029","article-title":"Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.","volume":"99","author":"Delea","year":"2005","unstructured":"Delea TE, Stanford R, Hagiwara M, Edelsberg JS, Oster G. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate. Int J Cardiol. 2005 Mar 10;99(1):117-24. | PubMed |","journal-title":"Int J Cardiol","ISSN":"http:\/\/id.crossref.org\/issn\/0167-5273","issn-type":"print"},{"issue":"6","key":"ref5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/eurjhf\/hfr020","article-title":"Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.","volume":"13","author":"D\u00fcngen","year":"2011","unstructured":"D\u00fcngen HD, Apostolovic S, Inkrot S, Tahirovic E, T\u00f6pper A, Mehrhof F, et al. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail. 2011 Jun;13(6):670-80. | CrossRef | PubMed |","journal-title":"Eur J Heart Fail","ISSN":"http:\/\/id.crossref.org\/issn\/1388-9842","issn-type":"print"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijcard.2005.06.067","article-title":"Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).","volume":"113","author":"Figulla","year":"2006","unstructured":"Figulla HR, Krzeminska-Pakula M, Wrabec K, Chochola J, Kalmbach C, Fridl P. Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial). Int J Cardiol.2006 Nov 10;113(2):153-60. | PubMed |","journal-title":"Int J Cardiol","ISSN":"http:\/\/id.crossref.org\/issn\/0167-5273","issn-type":"print"},{"issue":"20","key":"ref7","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1161\/01.CIR.99.20.2645","article-title":"Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.","volume":"99","author":"Kukin","year":"1999","unstructured":"Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varley C, Ocampo ON, Eng C. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation. 1999 May 25;99(20):2645-51. | PubMed |","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"issue":"8","key":"ref8","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.amjcard.2010.12.017","article-title":"Population-based analysis of class effect of \u03b2 blockers in heart failure.","volume":"107","author":"Lazarus","year":"2011","unstructured":"Lazarus DL, Jackevicius CA, Behlouli H, Johansen H, Pilote L. Population-based analysis of class effect of \u03b2 blockers in heart failure. Am J Cardiol. 2011 Apr 15;107(8):1196-202. | CrossRef | PubMed |","journal-title":"Am J Cardiol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/00129784-200606040-00006","article-title":"Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.","volume":"6","author":"Lombardo","year":"2006","unstructured":"Lombardo RM, Reina C, Abrignani MG, Rizzo PA, Braschi A, De Castro S. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Am J Cardiovasc Drugs. 2006;6(4):259-63. | PubMed |","journal-title":"Am J Cardiovasc Drugs","ISSN":"http:\/\/id.crossref.org\/issn\/1175-3277","issn-type":"print"},{"issue":"9","key":"ref10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cardfail.2011.05.001","article-title":"Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.","volume":"17","author":"Marazzi","year":"2011","unstructured":"Marazzi G, Volterrani M, Caminiti G, Iaia L, Massaro R, Vitale C, et al. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients. J Card Fail. 2011 Sep;17(9):703-9. | CrossRef | PubMed |","journal-title":"J Card Fail","ISSN":"http:\/\/id.crossref.org\/issn\/1071-9164","issn-type":"print"},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.CIR.102.5.546","article-title":"Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.","volume":"102","author":"Metra","year":"2000","unstructured":"Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation. 2000 Aug 1;102(5):546-51. | PubMed |","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"issue":"10","key":"ref12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jamainternmed.2014.3258","article-title":"Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.","volume":"174","author":"Pasternak","year":"2014","unstructured":"Pasternak B, Svanstr\u00f6m H, Melbye M, Hviid A. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure. JAMA Intern Med. 2014 Oct;174(10):1597-604. | CrossRef | PubMed |","journal-title":"JAMA Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/2168-6106","issn-type":"print"},{"issue":"10","key":"ref13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0002-9149(02)02778-9","article-title":"Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy.","volume":"90","author":"Piccirillo","year":"2002","unstructured":"Piccirillo G, Quaglione R, Nocco M, Naso C, Mois\u00e8 A, Lionetti M, et al. Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol. 2002 Nov 15;90(10):1113-7. | PubMed |","journal-title":"Am J Cardiol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"issue":"9377","key":"ref14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.","volume":"362","author":"Poole-Wilson","year":"2003","unstructured":"Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003 Jul 5;362(9377):7-13. | PubMed |","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1532-5415.2008.01682.x","article-title":"Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.","volume":"56","author":"Rector","year":"2008","unstructured":"Rector TS, Anand IS, Nelson DB, Ensrud KE. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure. J Am Geriatr Soc. 2008 Jun;56(6):1021-7. | CrossRef | PubMed |","journal-title":"J Am Geriatr Soc","ISSN":"http:\/\/id.crossref.org\/issn\/0002-8614","issn-type":"print"},{"issue":"12","key":"ref16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cardfail.2012.10.016","article-title":"Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.","volume":"18","author":"Shore","year":"2012","unstructured":"Shore S, Aggarwal V, Zolty R. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis. J Card Fail. 2012 Dec;18(12):919-24. | CrossRef | PubMed |","journal-title":"J Card Fail","ISSN":"http:\/\/id.crossref.org\/issn\/1071-9164","issn-type":"print"},{"key":"ref17","unstructured":"Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, et al. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET. Am Heart J. 2005 Feb;149(2):370-6. | PubMed | Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006 Jan;22(1):23-45. | PubMed | Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010 Jun;16(6):e1-194. | CrossRef | PubMed | McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jul;33(14):1787-847. | CrossRef | PubMed |"},{"issue":"16","key":"ref18","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines.","volume":"128","author":"Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):1810-52. | CrossRef | PubMed |","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref19","unstructured":"The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J) 2014. [on line]. | Link | A Phase III Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure. 2013 [on line] . | Link |"}],"container-title":["Medwave"],"original-title":["\u00bfEs el carvedilol superior a otros betabloqueadores en pacientes con insuficiencia cardiaca?"],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/6168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T15:56:08Z","timestamp":1562860568000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/6168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":20,"journal-issue":{"issue":"Suppl1","published-online":{"date-parts":[[2015,6,26]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2015.6168","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}